Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDNESII: Neostigmine vs Sugammadex Reversal
NCT02403063Phase 4Completed
- Sponsor
- OLV Hospital
- Start
- Sep 2015
- Primary completion
- Oct 2015
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by OLV Hospital. Started Sep 2015; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02403063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02403063.